The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys

A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease

(2010) Karl Kieburtz   ARCHIVES OF NEUROLOGY

Cognition-Enhancing Properties of Dimebon in a Rat Novel Object Recognition Task Are Unlikely to Be Associated with Acetylcholinesterase Inhibition or N-Methyl-D-aspartate Receptor Antagonism

(2010) M. Giorgetti et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Dimebolin is a 5-HT 6 antagonist with acute cognition enhancing activities

(2009) Hervé Schaffhauser et al.   BIOCHEMICAL PHARMACOLOGY

Uncertainty in the Translation of Preclinical Experiments to Clinical Trials. Why do Most Phase III Clinical Trials Fail?

(2009) Pedro Lowenstein et al.   CURRENT GENE THERAPY

Lost in translation: Problems and pitfalls in translating laboratory observations to clinical utility

(2008) Richard Simon   EUROPEAN JOURNAL OF CANCER

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

(2008) Rachelle S Doody et al.   LANCET

Evaluation of Dimebon in cellular model of Huntington's disease

(2008) Jun Wu et al.   Molecular Neurodegeneration

Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task

(2008) Jerry J. Buccafusco et al.   PSYCHOPHARMACOLOGY